The pharmaceutical landscape for blood sugar is shifting, and transdermal GLP-1 delivery systems represent a exciting breakthrough. Unlike subcutaneous injections, this approach offers a simpler way to deliver GLP-1 therapies. These devices gradually release the treatment through the epidermis offering a consistent amount of the therapeutic agen… Read More